Association of CYP2C19*2 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multiethnic population with drug-eluting stents.
Tan, Shirley Siang Ning
Association of CYP2C19*2 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multiethnic population with drug-eluting stents. [electronic resource] - Pharmacogenomics 08 2017 - 1225-1239 p. digital
Publication Type: Journal Article
1744-8042
10.2217/pgs-2017-0078 doi
Alleles
Cardiovascular Diseases--chemically induced
Clopidogrel
Cohort Studies
Cytochrome P-450 CYP2C19--genetics
Drug-Eluting Stents--adverse effects
Drug-Related Side Effects and Adverse Reactions--genetics
Female
Genotype
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors--adverse effects
Polymorphism, Genetic--genetics
Risk Factors
Ticlopidine--adverse effects
Association of CYP2C19*2 polymorphism with clopidogrel response and 1-year major adverse cardiovascular events in a multiethnic population with drug-eluting stents. [electronic resource] - Pharmacogenomics 08 2017 - 1225-1239 p. digital
Publication Type: Journal Article
1744-8042
10.2217/pgs-2017-0078 doi
Alleles
Cardiovascular Diseases--chemically induced
Clopidogrel
Cohort Studies
Cytochrome P-450 CYP2C19--genetics
Drug-Eluting Stents--adverse effects
Drug-Related Side Effects and Adverse Reactions--genetics
Female
Genotype
Humans
Male
Middle Aged
Platelet Aggregation Inhibitors--adverse effects
Polymorphism, Genetic--genetics
Risk Factors
Ticlopidine--adverse effects